Sargent Investment Group, LLC
Source: SEC Form 13F · as of Mar 2026Sargent Investment Group, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $42.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$42.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 45,348 | $9.9M |
| JNJJOHNSON & JOHNSON | 33,131 | $8.1M |
| LLYELI LILLY & Co | 6,066 | $5.6M |
| TEVATeva Pharmaceutical Industries Limited | 130,330 | $3.9M |
| ABTABBOTT LABORATORIES | 30,277 | $3.1M |
| MRKMerck & Co., Inc. | 25,599 | $3.1M |
| BMYBRISTOL MYERS SQUIBB CO | 35,930 | $2.2M |
| GILDGILEAD SCIENCES, INC. | 11,044 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,388 | $1.5M |
| MDWDMediWound Ltd. | 59,481 | $958K |
| IDXXIDEXX LABORATORIES INC /DE | 1,325 | $745K |
| PMPhilip Morris International Inc | 3,848 | $636K |
| ZTSZoetis Inc. | 4,371 | $517K |
| AMGNAMGEN INC | 1,294 | $455K |
| PFEPFIZER INC | 9,977 | $280K |
| GEHCGE HealthCare Technologies Inc. | 3,329 | $237K |
| ARDXARDELYX, INC. | 14,500 | $87K |
| NAGENiagen Bioscience, Inc. | 15,000 | $66K |
| LUCDLucid Diagnostics Inc. | 54,030 | $62K |
| MTNBMatinas BioPharma Holdings, Inc. | 12,720 | $6K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.